Real-time enrollment status for this li-fraumeni syndrome clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:16 PM UTC
| NCT Number | NCT04367246 |
| Recruiting Status | Recruiting |
| Condition | Li-Fraumeni Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | August 14, 2025 (Aug 14, 2025) |
As of July 13, 2026: Clinical trial NCT04367246 is currently recruiting participants. This clinical trial study for li-fraumeni syndrome is actively seeking new participants at 2 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04367246 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04367246 was last updated Aug 14, 2025 (August 14, 2025). HelloStudys verifies this status automatically.